Chrome Extension
WeChat Mini Program
Use on ChatGLM

Pharmacological Validation of SSc-ILD Mouse Model Bleomycin-Induced by Osmotic Minipump

crossref(2021)

University of Parma | University of Bologna | Erasmus University Rotterdam | Chiesi (Italy)

Cited 0|Views11
Abstract
Systemic sclerosis (SSc) is an autoimmune disease characterized by an excessive production and accumulation of collagen in the skin and internal organs often associated with interstitial lung disease (ILD). The unknown pathogenetic mechanisms of SSc-ILD and the lack of animal models mimicking the features of the human disease contribute to create a gap between the selection of antifibrotic drug candidates and effective therapies. Nintedanib (NINT) was used as a tool compound to validate the pharmacological response either on lung or skin fibrosis in a SSc-ILD mouse model. The model is based on the continuous infusion of bleomycin (BLM) by osmotic minipumps for 1 week in the C57BL/6 female mice. Longitudinal Micro-CT analysis highlighted a significant slowdown in lung fibrosis progression after NINT treatment, then confirmed by histology. However, no significant effect was observed on lung hydroxyproline content, inflammatory infiltrate and skin lipoatrophy. The modest pharmacological effect reported reflects the clinical outcome, lighting up the reliability of this model to serve as secondary screening to profile the best clinical drug candidates. Moreover, we have underlined the pivotal role of Micro-CT imaging, together describing the relevant readouts and the importance of their validation prior to use for drug discovery.
More
Translated text
Key words
Systemic Sclerosis
PDF
Bibtex
AI Read Science
AI Summary
AI Summary is the key point extracted automatically understanding the full text of the paper, including the background, methods, results, conclusions, icons and other key content, so that you can get the outline of the paper at a glance.
Example
Background
Key content
Introduction
Methods
Results
Related work
Fund
Key content
  • Pretraining has recently greatly promoted the development of natural language processing (NLP)
  • We show that M6 outperforms the baselines in multimodal downstream tasks, and the large M6 with 10 parameters can reach a better performance
  • We propose a method called M6 that is able to process information of multiple modalities and perform both single-modal and cross-modal understanding and generation
  • The model is scaled to large model with 10 billion parameters with sophisticated deployment, and the 10 -parameter M6-large is the largest pretrained model in Chinese
  • Experimental results show that our proposed M6 outperforms the baseline in a number of downstream tasks concerning both single modality and multiple modalities We will continue the pretraining of extremely large models by increasing data to explore the limit of its performance
Try using models to generate summary,it takes about 60s
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn
Chat Paper

要点】:本文通过使用渗透微泵系统连续输注博来霉素建立了一个系统性硬化病肺间质病变(SSc-ILD)小鼠模型,并用尼达尼布(NINT)验证了其药物反应性,发现模型对肺部纤维化的进展有一定的抑制效果,但皮肤脂肪萎缩无显著改善,显示了该模型在药物筛选中的可靠性。

方法】:研究采用C57BL/6雌性小鼠,通过渗透微泵系统连续一周输注博来霉素建立SSc-ILD模型,并使用尼达尼布进行治疗干预。

实验】:通过纵向Micro-CT分析及组织学验证,发现尼达尼布治疗能显著减缓肺部纤维化的进展,但对肺羟脯氨酸含量、炎症浸润和皮肤脂肪萎缩无明显影响,实验使用的数据集为C57BL/6小鼠的Micro-CT影像及组织学数据。